Bypass graft failure affects up to 50 percent of saphenous vein grafts within ten years of the original CABG procedure. When grafts occlude, the two primary revascularisation options are redo coronary artery bypass grafting and percutaneous coronary intervention via angioplasty and stenting. Redo CABG offers more complete revascularisation for multi-vessel or diffuse disease. PCI carries lower procedural risk and shorter recovery for focal graft lesions. The choice between them is determined by graft anatomy, native disease progression, left ventricular function, and available conduit for a second operation.
According to Dr. Vishal Khullar, a Cardiac Surgeon in Mumbai, “Blocked grafts don’t automatically mean a second bypass. Angioplasty handles focal graft lesions well. But when native disease has progressed, or multiple grafts have failed, redo surgery gives you coverage that stenting simply can’t match.”
Not every failed graft points back to the operating theatre. A few things push it that direction specifically. The decision framework matters more than most patients realise when they first hear the words blocked graft.
Graft type matters: Venous grafts fail more than arterial ones over time. When multiple vein grafts are gone and the internal mammary is still open, the surgeon has fewer healthy vessels left to use for a second bypass operation.
Native disease progression: Sometimes the original grafts are fine. It’s the native coronary arteries that have developed new blockages downstream. Angioplasty targets focal lesions. It doesn’t touch widespread native disease. Redo bypass does. That distinction matters more than any other single factor.
Left ventricular function: A patient with preserved ejection fraction tolerates redo surgery differently from someone with an ejection fraction already below 35 percent. Low function doesn’t rule it out. It just changes the numbers going in and shifts where the risk sits.
Previous mammary artery use: If the left internal mammary was used first time and it’s still patent, a redo surgeon has fewer conduit options left. That shifts the risk profile and sometimes pushes the team toward stenting individual lesions instead.
When multi-vessel failure, native disease progression, and preserved function line up together, the case for redo surgery becomes difficult to argue against.
Blocked grafts and not sure which way to go?
Two paths. Different clinical profiles. Here’s what the comparison actually shows.
|
Feature |
Redo Bypass (CABG) |
Angioplasty (PCI) |
|
Best for |
Multi-vessel or diffuse graft failure |
Focal graft lesion, single vessel |
|
Invasiveness |
Open chest, general anaesthesia |
Catheter-based, local anaesthesia |
|
Recovery |
Six to twelve weeks |
Two to five days |
|
Completeness of revascularisation |
High, covers multiple vessels |
Limited to targeted lesion |
|
Repeat intervention risk |
Lower long term |
Higher if restenosis occurs |
|
Mortality risk |
Higher upfront in redo cases |
Lower procedural risk |
Revascularisation coverage: Redo bypass restores flow to multiple vessels in one operation. Angioplasty treats one lesion at a time. Three or four failing grafts stented separately means more procedures, more restenosis risk at every site, and a longer road overall.
Procedural risk in redo surgery: Going back into the chest the second time is categorically harder. Adhesions. Scar tissue. Patent grafts sitting close to the sternum. That’s not a reason to avoid it. It’s a reason to pick the surgeon carefully.
Recovery difference: PCI for a focal vein graft lesion. Home in two days. Redo CABG. Full surgical recovery. For older patients or those carrying other conditions, that gap matters as much as the revascularisation result itself.
Long-term patency: Drug-eluting stents in bypass grafts work reasonably for focal disease. But venous graft stenting has worse long-term patency than native coronary stenting. Redo surgery using arterial conduits, where those are still available, still delivers the most durable result over time.
For a deeper understanding of how angioplasty works and when it’s the primary choice, read our blog on angioplasty.
Dr. Vishal Khullar is the Director of Cardiovascular and Thoracic Surgery, Heart and Lung Transplant at Fortis Hospital Mulund and Fortis S.L. Raheja Hospital, Mumbai. Over 30 years in the field. Training at Cleveland Clinic and Mayo Clinic in the USA. More than 7,000 completed procedures, including a high volume of redo sternotomy and complex re-operative cases.
His redo bypass assessments are direct and thorough. Patients with blocked grafts get a clear answer on whether surgery or angioplasty fits their anatomy, not a vague second opinion. Call +91 99870 77880 to book your consultation.
Yes. Scar tissue and adhesions raise operative risk compared to a first bypass.
No. It works best for focal lesions. Diffuse graft disease needs surgical assessment.
Vein grafts can fail within months. Most significant failures occur within ten years.
Not always. Some graft failures are silent and detected only on imaging.
WhatsApp us

